431 related articles for article (PubMed ID: 31727783)
1. Targeting the interleukin-17 immune axis for cancer immunotherapy.
Vitiello GA; Miller G
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727783
[TBL] [Abstract][Full Text] [Related]
2. T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer.
Chang SH
Arch Pharm Res; 2019 Jul; 42(7):549-559. PubMed ID: 30941641
[TBL] [Abstract][Full Text] [Related]
3. Th17 Cell Plasticity and Functions in Cancer Immunity.
Guéry L; Hugues S
Biomed Res Int; 2015; 2015():314620. PubMed ID: 26583099
[TBL] [Abstract][Full Text] [Related]
4. Novel Insight Into the Molecular and Metabolic Mechanisms Orchestrating IL-17 Production in γδ T Cells.
Chen X; Morrissey S; Chen F; Yan J
Front Immunol; 2019; 10():2828. PubMed ID: 31849992
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer.
Song Y; Yang JM
Biochem Biophys Res Commun; 2017 Nov; 493(1):1-8. PubMed ID: 28859982
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type.
Fabre J; Giustiniani J; Garbar C; Antonicelli F; Merrouche Y; Bensussan A; Bagot M; Al-Dacak R
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589729
[TBL] [Abstract][Full Text] [Related]
7. [Do Th17 cells play an important role in the pathogenesis and prognosis of ovarian cancer?].
Winkler I; Gogacz M; Rechberger T
Ginekol Pol; 2012 Apr; 83(4):295-300. PubMed ID: 22712263
[TBL] [Abstract][Full Text] [Related]
8. Evolved to protect, designed to destroy: IL-17-producing γδ T cells in infection, inflammation, and cancer.
Agerholm R; Bekiaris V
Eur J Immunol; 2021 Sep; 51(9):2164-2177. PubMed ID: 34224140
[TBL] [Abstract][Full Text] [Related]
9. IL-33/ST2 as a potential target for tumor immunotherapy.
Jiang W; Lian J; Yue Y; Zhang Y
Eur J Immunol; 2021 Aug; 51(8):1943-1955. PubMed ID: 34131922
[TBL] [Abstract][Full Text] [Related]
10. IL-17, IL-21, and IL-22 Cytokines of T Helper 17 Cells in Cancer.
Nalbant A
J Interferon Cytokine Res; 2019 Jan; 39(1):56-60. PubMed ID: 30562123
[TBL] [Abstract][Full Text] [Related]
11. The role of T helper 17 and regulatory T cells in tumor microenvironment.
Najafi S; Mirshafiey A
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):16-24. PubMed ID: 30714422
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis.
Qian X; Chen H; Wu X; Hu L; Huang Q; Jin Y
Cytokine; 2017 Jan; 89():34-44. PubMed ID: 26883678
[TBL] [Abstract][Full Text] [Related]
13. IL-17 Signaling in the Tumor Microenvironment.
Gorczynski RM
Adv Exp Med Biol; 2020; 1240():47-58. PubMed ID: 32060887
[TBL] [Abstract][Full Text] [Related]
14. The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?
Joerger M; Finn SP; Cuffe S; Byrne AT; Gray SG
Expert Opin Ther Targets; 2016 Nov; 20(11):1339-1356. PubMed ID: 27353429
[TBL] [Abstract][Full Text] [Related]
15. Role of IL-17 and IL-22 in autoimmunity and cancer.
Blake SJ; Teng MW
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
[TBL] [Abstract][Full Text] [Related]
16. Suppressive IL-17A
Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
[TBL] [Abstract][Full Text] [Related]
17. The paradox of Th17 cell functions in tumor immunity.
Asadzadeh Z; Mohammadi H; Safarzadeh E; Hemmatzadeh M; Mahdian-Shakib A; Jadidi-Niaragh F; Azizi G; Baradaran B
Cell Immunol; 2017 Dec; 322():15-25. PubMed ID: 29103586
[TBL] [Abstract][Full Text] [Related]
18. [The role of Th17 cells in anti-cancer immunity].
Hus I; Maciag E; Roliński J
Postepy Hig Med Dosw (Online); 2010 May; 64():244-50. PubMed ID: 20498501
[TBL] [Abstract][Full Text] [Related]
19. The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.
Van Acker HH; Campillo-Davo D; Roex G; Versteven M; Smits EL; Van Tendeloo VF
Cytokine Growth Factor Rev; 2018 Jun; 41():54-64. PubMed ID: 29773448
[TBL] [Abstract][Full Text] [Related]
20. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer.
Chen D; Hu Q; Mao C; Jiao Z; Wang S; Yu L; Xu Y; Dai D; Yin L; Xu H
Cell Immunol; 2012; 272(2):166-74. PubMed ID: 22082565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
